Increased Phospho-AKT in Blood Cells from LRRK2 G2019S Mutation Carriers.

Ann Neurol · 2022 · PMC9827833 · PMID 35929078

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Interestingly, patients with G2019S L2PD under LRRK2 inhibition showed a trend toward lower levels of P‐Ser‐473‐AKT, which warrants further investigation.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.